Yahoo
HKSE - Delayed Quote HKD

Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)

19.260 +0.620 (+3.33%)
As of 2:13:09 PM GMT+8. Market Open.
Chart Range Bar
Loading chart for 2190.HK
  • Previous Close 18.640
  • Open 18.960
  • Bid 19.160 x --
  • Ask 19.270 x --
  • Day's Range 18.410 - 19.420
  • 52 Week Range 17.100 - 28.000
  • Volume 282,500
  • Avg. Volume 553,902
  • Market Cap (intraday) 6.353B
  • Beta (5Y Monthly) 0.33
  • PE Ratio (TTM) 18.00
  • EPS (TTM) 1.070
  • Earnings Date --
  • Forward Dividend & Yield 0.25 (1.35%)
  • Ex-Dividend Date May 27, 2026
  • 1y Target Est 31.32

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. The company's peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as covers hemodialysis access, arterial, venous, peripheral embolization intervention, and other intervention products. In addition, the company provides technical consultation and services, as well as imports materials. It serves patients and physicians. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.

www.zyloxtb.com

1,214

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2190.HK
15.32%
HANG SENG INDEX (^HSI)
8.65%

1-Year Return

2190.HK
17.61%
HANG SENG INDEX (^HSI)
9.62%

3-Year Return

2190.HK
84.61%
HANG SENG INDEX (^HSI)
35.89%

5-Year Return

2190.HK
33.31%
HANG SENG INDEX (^HSI)
6.72%

Analyst Insights

View More

Analyst Price Targets

29.28
31.32 Average
19.260 Current
33.39 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    25.25%

  • Return on Assets (ttm)

    5.13%

  • Return on Equity (ttm)

    9.82%

  • Revenue (ttm)

    1.21B

  • Net Income Avi to Common (ttm)

    304.88M

  • Diluted EPS (ttm)

    1.070

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.48B

  • Total Debt/Equity (mrq)

    13.70%

  • Levered Free Cash Flow (ttm)

    115.53M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: